You are here

Press Releases

International Biophysics Corporation, a global medical device manufacturer based in Austin, Texas, announced they have received FDA 510k clearance for their FloPump 32 centrifugal disposable heart pump.

DUBLIN — January 16, 2018 — Medtronic plc (NYSE:MDT) today announced that the company's Neurovascular business unit received U.S. Food and Drug Administration (FDA) clearance of the Riptide(TM) Aspiration System, adding a valuable tool to the Acute Ischemic Stroke (AIS) product portfolio.

Kirk N. Garratt, M.Sc, M.D, has been appointed medical director of Christiana Care Health System’s Center for Heart & Vascular Health. Dr. Garratt succeeds Tim Gardner, M.D., who retired after 12 years of dedication to Christiana Care and the Delaware community.

DUBLIN — January 11, 2018 — Medtronic plc (NYSE:MDT) today announced the publication of results from the 'Spasticity In Stroke-Randomised Study' (SISTERS) trial in the Journal of Neurology, Neurosurgery & Psychiatry (JNNP). These results demonstrate the superiority of Medtronic ITB TherapySM with Lioresal®Intrathecal (baclofen injection) delivered via the SynchroMed(TM) II Infusion System compared to conventional medical management (CMM) for the reduction of severe post-stroke spasticity (PSS) in adults.

DUBLIN, Ohio, January 11, 2018 — Cordis, a Cardinal Health company, and Medinol today announced that the first commercial cases using the EluNIR™ drug-eluting stent (DES) in the United States were performed at New York-Presbyterian Hospital/Columbia University Medical Center in New York City and the Piedmont Heart Institute in Atlanta.

FLAGSTAFF, Ariz. (JANUARY 3, 2018) — W. L. Gore & Associates, Inc. (Gore) today announced the first implant of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the United States.

DURHAM, N.C., Jan. 9, 2018 — Micell Technologies, Inc. announced the recent online publication of five-year data from the DESSOLVE I and II trials.

Jupiter, Fla. — January 8, 2018 — Excel Medical launches the first FDA-cleared patient surveillance system. The WAVE Clinical Platform is the first of its kind cleared for marketing.

Abbott (NYSE: ABT) today announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for the Quadra Assura MPTM Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Fortify AssuraTM Implantable Cardioverter Defibrillator (ICD), two of the company's most widely-used high voltage medical devices.

Medtronic plc (NYSE: MDT) announced today that Bob White, previously Senior Vice President and President of Medtronic's Asia Pacific (APAC) Region, has been named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group (MITG). In addition, the company announced that Chris Lee, Senior Vice President and President of Medtronic's Greater China Region, will assume the position of APAC Region President.

San Diego, Calif. — Renova™ Therapeutics, a biotechnology company developing gene and peptide-based treatments for cardiovascular and metabolic diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the company’s lead product candidate, RT-100 AC6 gene transfer (Ad5.hAC6), for the treatment of heart failure with reduced ejection fraction (HFrEF).

Malvern, Pa., December 11, 2017 — Siemens Healthineers has launched teamplay Cardio, a new cardiology dashboard application within the Siemens Healthineers Digital Ecosystem. Part of teamplay—the company’s cloud-based network that enables access to metrics from a facility’s imaging fleet—this new application helps cardiology departments better understand their performance and status.

ROSEMONT, Ill., Dec. 11, 2017 — Eating yogurt on a regular basis may help reduce measures of chronic inflammation in women and support a healthy digestive system, researchers from University of Wisconsin-Madison College of Agricultural and Life Sciences (UW-Madison) report in the British Journal of Nutrition.

PLAINSBORO, N.J., Dec. 5, 2017 — Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) approved its New Drug Application (NDA) for OZEMPIC® (semaglutide) injection 0.5 mg or 1 mg, a once-weekly glucagon-like peptide (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.

Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, announced today that Houston Methodist DeBakey Heart & Vascular Center has launched the first vascular robotic program in the Houston area with the installation of two CorPath® GRX Systems. In addition and as part of the program launch, Corindus will partner with Houston Methodist to develop a Global Center of Excellence that will seek to advance clinical research on robotics and to train interventional cardiologists on robotic-assisted percutaneous coronary interventions (PCI).

BioTelemetry, Inc., the leading mobile and wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today a partnership with Apple to provide cardiac monitoring services in conjunction with the Apple Heart Study.

DUBLIN, Ohio, November 30, 2017 — Cordis, a Cardinal Health company, and Medinol today announced United States Food and Drug Administration (FDA) approval of the EluNIR™ drug-eluting stent (DES) for the treatment of patients with narrowing or blockages to their coronary arteries.

MADRID — Nov. 28, 2017 — MedLumics, a medical device company developing an optically guided cardiac ablation platform for the treatment of Atrial fibrillation (AF), announced today it has appointed James Greene as Chief Executive Officer and named Giovanni Leo to the board of directors.

Digisonics and Medis have partnered to provide a comprehensive single system solution that adds cardiac MR to Digisonics congenital Echo and Cath system. 

New York, NY (November, 21, 2017) — This Thanksgiving week, WCBS-TV will air “The Resilient Heart,” a feature documentary that explores the keys to eradicating heart disease on a worldwide scale. The film will air on Friday, November 24, from 10 am to 11 am on WCBS (channel 2) and on Sunday, November 26, from 10 pm to 11 pm on WLNY (channels 10/55).

Pages